226 related articles for article (PubMed ID: 7363085)
1. Effect of discrete kainic acid-induced lesions of corpus caudatus and globus pallidus on glutamic acid decarboxylase of rat substantia nigra.
Di Chiara G; Morelli M; Porceddu ML; Mulas M; Del Fiacco M
Brain Res; 1980 May; 189(1):193-208. PubMed ID: 7363085
[TBL] [Abstract][Full Text] [Related]
2. Glutamic acid decarboxylase (GAD) activity in the rat substantia nigra after discrete bilateral kainic acid-induced lesions of the caudate-putamen and globus pallidus: correlation with locomotor activity.
Al-Shabibi UM; Davies JA
Brain Res; 1981 Jun; 213(2):460-6. PubMed ID: 7248771
[TBL] [Abstract][Full Text] [Related]
3. Lesions of the globus pallidus, entopeduncular nucleus and substantia nigra alter dopamine mediated circling behaviour.
Dewar D; Jenner P; Marsden CD
Exp Brain Res; 1983; 52(2):281-92. PubMed ID: 6641888
[TBL] [Abstract][Full Text] [Related]
4. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.
Brownstein MJ; Mroz EA; Tappaz ML; Leeman SE
Brain Res; 1977 Oct; 135(2):315-23. PubMed ID: 922480
[TBL] [Abstract][Full Text] [Related]
5. A striatal source of glutamic acid decarboxylase activity in the substantia nigra.
Nagy JI; Fibiger HC
Brain Res; 1980 Apr; 187(1):237-42. PubMed ID: 7357470
[No Abstract] [Full Text] [Related]
6. Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum.
Oertel WH; Schmechel DE; Brownstein MJ; Tappaz ML; Ransom DH; Kopin IJ
J Histochem Cytochem; 1981 Aug; 29(8):977-80. PubMed ID: 7024401
[TBL] [Abstract][Full Text] [Related]
7. The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions.
Walaas I; Fonnum F
Brain Res; 1979 Nov; 177(2):325-36. PubMed ID: 497834
[TBL] [Abstract][Full Text] [Related]
8. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons.
Kincaid AE; Albin RL; Newman SW; Penney JB; Young AB
Neuroscience; 1992 Dec; 51(3):705-18. PubMed ID: 1488118
[TBL] [Abstract][Full Text] [Related]
9. The pallido-subthalamic projection in rat: anatomical and biochemical studies.
van der Kooy D; Hattori T; Shannak K; Hornykiewicz O
Brain Res; 1981 Jan; 204(2):253-68. PubMed ID: 7459631
[TBL] [Abstract][Full Text] [Related]
10. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
Jessell TM; Emson PC; Paxinos G; Cuello AC
Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection.
Nitsch C; Riesenberg R
Brain Res; 1988 Sep; 461(1):127-42. PubMed ID: 3224272
[TBL] [Abstract][Full Text] [Related]
12. Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus.
Billings LM; Marshall JF
J Neurosci; 2004 Mar; 24(12):3094-103. PubMed ID: 15044549
[TBL] [Abstract][Full Text] [Related]
13. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection.
Nagy JI; Carter DA; Fibiger HC
Brain Res; 1978 Dec; 158(1):15-29. PubMed ID: 21348349
[TBL] [Abstract][Full Text] [Related]
14. The GABA neurons and their axon terminals in rat corpus striatum as demonstrated by GAD immunocytochemistry.
Ribak CE; Vaughn JE; Roberts E
J Comp Neurol; 1979 Sep; 187(2):261-83. PubMed ID: 226567
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of differential substance P-, met-enkephalin-, and glutamic-acid-decarboxylase-containing cell body and axon distributions in the corpus striatum of the cat.
Beckstead RM; Kersey KS
J Comp Neurol; 1985 Feb; 232(4):481-98. PubMed ID: 2579980
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat.
Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
Brain Res; 1979 Nov; 176(2):273-84. PubMed ID: 40667
[TBL] [Abstract][Full Text] [Related]
17. GABAergic nerve terminals decrease in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways.
Ribak CE; Vaughn JE; Roberts E
Brain Res; 1980 Jun; 192(2):413-20. PubMed ID: 7378797
[TBL] [Abstract][Full Text] [Related]
18. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
Palkovits M; Lovas G; Horváth E
Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
[TBL] [Abstract][Full Text] [Related]
19. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
[TBL] [Abstract][Full Text] [Related]
20. Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.
McGeer PL; McGeer EG; Wada JA; Jung E
Brain Res; 1971 Sep; 32(2):425-31. PubMed ID: 4944072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
